News
TargED reports positive Phase 1 results for TGD001 at ASH 2025
TargED Biopharmaceuticals has announced positive results from a Phase 1 first-in-human study of its lead investigational thrombolytic fusion protein, TGD001, presented in an oral session at the American Society of Hematology (ASH) Annual Meeting 2025 in OrAquaWomb and Medsim receive Stimuleringsfonds MRE funding for neonatal innovation
AquaWomb and Medsim have been awarded funding from the Stimuleringsfonds Metropoolregio Eindhoven (MRE) to accelerate the development of innovative solutions for extreme premature births. Within this collaboration, AquaWomb and Medsim are developiTargED raises €21.5 million Series A extension to accelerate clinical development of targeted thrombolytic therapy (Alumni news)
TargED Biopharmaceuticals B.V., a clinical-stage biotechnology company developing next-generation targeted treatments for thrombotic diseases, has secured a €21.5 million Series A extension, bringing its total Series A funding to over €60 million.Netherlands Academy of Engineering welcomes twenty new members
The Netherlands Academy of Engineering (NAE) has today installed twenty new members: fifteen Fellows and five Young Engineers.3D-printed prosthetics featured in NRC’s Jong geleerd
Today, NRC highlights the impact of medical innovation in its Jong geleerd section, featuring a powerful story about the real-world application of 3D-printed prosthetics. The article tells the story of a woman walking a muddy path while cATRO wins Startup Pitch Award at HealthTech Investor Summit 2025
ATRO has been awarded the Startup Pitch Award at the HealthTech Investor Summit (HTIS) 2025, where co-founder Maarten van der Zanden ranked first in the startup pitch competition. The award recognises ATRO’s work on developing the world’s first ar819 Capital Partners acquires Smart Industry and Medtech TTT funds
819 Capital Partners has acquired the Smart Industry and Medtech TTT funds from Innovation Industries, marking an important milestone in the continued development of the Dutch innovation and venture ecosystem. With this strategic acquisition, 23 pPre-announcement: Venture Challenge 2026 call expected in January and May
In 2026, the LifeSciences@Work Venture Challenge will again run two editions for early-stage Life Sciences & Health startup teams: a Spring and a Winter round.